Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Poster presentation

Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort

Authors: M Cervero, C García Lacalle, JL Agud, R Torres Perea, E García-Benaya, J Jusdado, C Pérez Pons, M del Álamo

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Several studies have shown a high frequency of vitamin D deficiency among HIV patients. Several studies have ascribed these low levels of vitamin D to antiretroviral treatment, especially efavirenz. Tenofovir has been related to changes of bone mineralization in SIV-infected rhesus monkeys and with loss of bone mineral density in children. Adequate vitamin D stores have the potential of an improvement of immune status, lessening of cardiovascular risk and beneficial effects on certain neoplastic disorders. …
Metadata
Title
Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort
Authors
M Cervero
C García Lacalle
JL Agud
R Torres Perea
E García-Benaya
J Jusdado
C Pérez Pons
M del Álamo
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-P104

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue

Poster presentation

Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co-infected patients

Poster presentation

PK/PD modeling supports the dose-escalation decision in VIKING

Oral presentation

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

Poster presentation

Correlates of hepatic stiffness by FibroScan© in a multicentric Italian cohort of HIV-infected patients

Poster presentation

Continuing burden of HIV late presenters in the North East of England 2009

Poster presentation

Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits